Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2026-01-21 @ 9:44 PM
Study NCT ID:
NCT02643420
Status:
COMPLETED
Last Update Posted:
2022-03-02
First Post:
2015-12-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)
Sponsor:
Spectrum Pharmaceuticals, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01-19
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-29
First Submit QC Date:
None
Study First Post Date:
2015-12-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-01-11
Results First Submit QC Date:
None
Results First Post Date:
2022-03-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-02-05
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-02-28
Last Update Post Date:
2022-03-02
Last Update Post Date Type:
ACTUAL